NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
0.970
+0.020 (2.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
NextCure Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 27 | 32 | 39 | 166 | 300 | 1,546 | |
| Market Cap Growth | 6.72% | -18.77% | -76.37% | -44.81% | -80.57% | - | |
| Enterprise Value | -42 | -80 | -130 | -70 | 13 | 1,367 | |
| Last Close Price | 0.97 | 1.14 | 1.41 | 6.00 | 10.90 | 56.33 | |
| PS Ratio | - | - | - | - | 13.42 | 243.56 | |
| PB Ratio | 0.36 | 0.28 | 0.23 | 0.71 | 1.02 | 4.81 | |
| P/TBV Ratio | 0.51 | 0.28 | 0.23 | 0.71 | 1.02 | 4.81 | |
| EV/Sales Ratio | - | - | - | - | 0.58 | 215.34 | |
| Debt / Equity Ratio | 0.08 | 0.06 | 0.04 | - | 0.01 | 0.02 | |
| Asset Turnover | - | - | - | - | 0.07 | 0.03 | |
| Quick Ratio | 8.72 | 15.85 | 17.60 | 33.23 | 27.45 | 22.24 | |
| Current Ratio | 9.07 | 16.38 | 17.97 | 34.48 | 27.89 | 22.60 | |
| Return on Equity (ROE) | -57.93% | -44.49% | -37.28% | -26.33% | -11.90% | -15.45% | |
| Return on Assets (ROA) | -32.86% | -27.08% | -22.25% | -16.11% | -7.77% | -9.30% | |
| Return on Capital (ROIC) | -35.21% | -28.59% | -23.25% | -16.67% | -8.26% | -10.59% | |
| Earnings Yield | -215.41% | -197.18% | -190.83% | -41.86% | -12.19% | -2.18% | |
| FCF Yield | -165.74% | -169.11% | -143.00% | -35.98% | -17.34% | -2.52% | |
| Buyback Yield / Dilution | -0.48% | -0.33% | -0.46% | -0.30% | -75.41% | -1045.78% | |
| Total Shareholder Return | -0.48% | -0.33% | -0.46% | -0.30% | -75.41% | -1045.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.